FDA Advisory Panel Backs Broad Flexibility in COVID-19 Vaccine Updates
A panel of scientific experts advising the U.S. Food and Drug Administration (FDA) has unanimously recommended a flexible approach for this year’s COVID-19 vaccines. This allows the agency to retain the current vaccine composition or update it to better match the variants currently in circulation. Concerns Over New Vaccine Approval Framework During the advisory […]
Continue Reading